SHM sent a support letter to Reps. Blumenauer and Mullin for their legislation, the Overdose Prevention and Patient Safety Act.

SHM urges Congress to take action to address the opioid crisis facing the United States.

SHM urges Congress to act now to restore funding for CHIP and ensure millions of children nationwide have access to health care. We stand ready to help move this important priority forward.

SHM submitted comments on this year’s fee schedule including evaluation and management guidelines, PQRS reporting, and MACRA.

SHM submitted comments to CMS on proposed changes to the Quality Payment Program (QPP)/MACRA including facility alignment.

SHM submitted comments regarding observation care and APM thresholds to the Ways and Means Health Subcommittee.

Along with other organizations, SHM signs on to a letter voicing concerns on provisions of the Program Integrity to the Provider Enrollment Process proposed rule.

SHM sends a letter to the Senate Health, Education, Labor and Pensions Committee in support of Scott Gottlieb, MD as Commissioner of FDA.

SHM comments on the quality improvement section of the proposed Common Rule changes from the Office for Human Resarch Protections (OHRP)

SHM submitted comments to CMS surrounding the Medicare Access and CHIP Reauthorization Act (MACRA), that replaced the SGR and makes changes to physician payment.